Campus partners part of collaboration to fast-track radical new brain health technologies

Employers from Cambridge Biomedical Campus are part of a large team from across the Cambridge life sciences, technology and business worlds involved in a multi-million-pound, three-year collaboration with the Advanced Research and Invention Agency (ARIA), the UK Government’s new research funding agency.

ARIA’s Scalable Neural Interfaces opportunity space is exploring ways to make brain health technologies more precise, less invasive, and applicable to a broader range of diseases such as depression, dementia, chronic pain, epilepsy and injuries to the nervous system.

Campus-based organisations who were part of the bid include Cambridge University Health Partners and the Milner Therapeutics Institute.

Cambridge’s partnership with ARIA will create a home for original thinkers who are struggling to find the funding, space and mentoring needed to stress-test their radical ideas. It will scour the UK for innovators from any background with a highly ambitious concept for a technology that could transform brain health. The very best will be offered the resources to test and then scale up their idea at pace, so it can be brought to patients across the world quickly and affordably.